MA51186A - Matériels et procédés pour traiter la dystrophie des cônes et des bâtonnets autosomique dominante - Google Patents

Matériels et procédés pour traiter la dystrophie des cônes et des bâtonnets autosomique dominante

Info

Publication number
MA51186A
MA51186A MA051186A MA51186A MA51186A MA 51186 A MA51186 A MA 51186A MA 051186 A MA051186 A MA 051186A MA 51186 A MA51186 A MA 51186A MA 51186 A MA51186 A MA 51186A
Authority
MA
Morocco
Prior art keywords
dystrophy
stick
treating
materials
methods
Prior art date
Application number
MA051186A
Other languages
English (en)
Inventor
Shuying He
Akiko Noma
Abraham Scaria
Ryo Takeuchi
Original Assignee
Bayer Healthcare Llc
Crispr Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc, Crispr Therapeutics Ag filed Critical Bayer Healthcare Llc
Publication of MA51186A publication Critical patent/MA51186A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y406/00—Phosphorus-oxygen lyases (4.6)
    • C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
    • C12Y406/01002—Guanylate cyclase (4.6.1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA051186A 2017-12-14 2018-12-14 Matériels et procédés pour traiter la dystrophie des cônes et des bâtonnets autosomique dominante MA51186A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762598682P 2017-12-14 2017-12-14
US201862670378P 2018-05-11 2018-05-11
US201862675306P 2018-05-23 2018-05-23
US201862693100P 2018-07-02 2018-07-02

Publications (1)

Publication Number Publication Date
MA51186A true MA51186A (fr) 2020-10-21

Family

ID=65268994

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051186A MA51186A (fr) 2017-12-14 2018-12-14 Matériels et procédés pour traiter la dystrophie des cônes et des bâtonnets autosomique dominante

Country Status (5)

Country Link
US (2) US10995328B2 (fr)
EP (1) EP3724342A1 (fr)
CA (1) CA3084733A1 (fr)
MA (1) MA51186A (fr)
WO (1) WO2019116349A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3074466A1 (fr) 2017-08-28 2019-03-07 University Of Florida Research Foundation, Incorporated Methodes et compositions pour traiter une dystrophie retinienne des cones et des batonnets
CA3086045A1 (fr) 2017-12-19 2019-06-27 Akouos, Inc. Administration d'anticorps therapeutiques mediee par aav a l'oreille interne
WO2021026318A2 (fr) * 2019-08-06 2021-02-11 The Penn State Research Foundation Systèmes crispr/cas9 modifiés pour la régulation simultanée à long terme de cibles multiples
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
WO2022072718A1 (fr) 2020-09-30 2022-04-07 Nobell Foods, Inc. Protéines de lait recombinantes et compositions les comprenant
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
IL303317A (en) 2020-12-01 2023-07-01 Akouos Inc ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA
AU2022216614B2 (en) 2021-02-05 2026-03-05 Christiana Care Gene Editing Institute, Inc. Methods of and compositions for reducing gene expression and/or activity
EP4370695A1 (fr) * 2021-07-14 2024-05-22 Meiragtx UK II Limited Thérapie génique de retgc
EP4405490A2 (fr) * 2021-09-23 2024-07-31 Scribe Therapeutics Inc. Vecteurs à auto-inactivation d'édition génique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2668279A1 (fr) * 2011-01-27 2013-12-04 Centre National De La Recherche Scientifique Porc transgénique avec gucy2d mutant comme modèle de la dystrophie des cônes
CN110997908A (zh) * 2017-06-09 2020-04-10 爱迪塔斯医药公司 工程化的cas9核酸酶
CA3074466A1 (fr) * 2017-08-28 2019-03-07 University Of Florida Research Foundation, Incorporated Methodes et compositions pour traiter une dystrophie retinienne des cones et des batonnets

Also Published As

Publication number Publication date
US10995328B2 (en) 2021-05-04
WO2019116349A1 (fr) 2019-06-20
US20220081680A1 (en) 2022-03-17
US20200385696A1 (en) 2020-12-10
EP3724342A1 (fr) 2020-10-21
CA3084733A1 (fr) 2019-06-20

Similar Documents

Publication Publication Date Title
EP3493827A4 (fr) Compositions et procédés pour immunothérapie
EP3471745A4 (fr) Procédés et compositions pour réduire le stress oxydatif
EP3384274A4 (fr) Dispositifs et procédés de caracterisation d'échantillon
EP3331571A4 (fr) Compositions et procédés pour traiter des infections virales
EP3519946A4 (fr) Accélérateurs matériels et procédés pour opérations de délestage
IL249335A0 (en) Methods for processing material and related apparatus
EP3334358A4 (fr) Générateur et procédés pour électro-chirurgie
PT3496739T (pt) Composições compreendendo polipéptidos actriia para uso no tratamento de hipertensão pulmonar
SI3239378T1 (sl) Naprava in postopek za izdelavo kopren iz brezkončnih filamentov
MA53246A (fr) Composés et procédés pour favoriser la myélinisation
EP3635100A4 (fr) Compositions et procédés pour exprimer l'otoferline
EP3307296A4 (fr) Procédés et compositions pour traiter des états associés au vieillissement
EP3519572A4 (fr) Composés et procédés pour réduire l'expression de tau
EP3494234A4 (fr) Procédés pour la caractérisation génomique
EP3349908A4 (fr) Dispositif et procédé pour enlever une matière indésirable
EP3319981A4 (fr) Compositions et procédés de lutte contre les phytoravageurs
LT3111148T (lt) Biralų džiovinimo būdas
EP3298151A4 (fr) Procédés et compositions pour déterminer le ph
IL250526B (en) Devices and methods for analyzing the throughput of microfluidic devices
EP3530261A4 (fr) Matériau fluorescent pour produits cosmétiques, et produit cosmétique
PL2927365T3 (pl) Sposób suszenia materiałów pranych oraz urządzenie do jego realizowania
EP3600359A4 (fr) Procédés et matériaux pour le traitement de fistules
PL3509064T3 (pl) Urządzenie odbiorcze strumieni audio i sposób
PL3137209T3 (pl) Funkcjonalizowany materiał nośnikowy i sposoby wytwarzania oraz stosowania funkcjonalizowanego materiału nośnikowego
EP3359553A4 (fr) Compositions et procédés pour traiter la rétinopathie diabétique